John C.k. Milligan IV is President & Secretary at TherapeuticsMD, Inc. (TXMD). They have made 13 open-market trades across 1 company since 2014, most recently 2021-05-11.
CIK 0001532230
3 open-market purchases totalling $275K since 2019, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXMD | 1,796,955 | $3.3M |
Shares reported on the most recent Form 4, priced at the 2021-05-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXMD | SELL | 2021-05-11 | 2021-05-12 | $1.04 | $46K | +18.4% | +28.2% | -10.7% |
| TXMD | BUY | 2019-10-25 | 2019-10-29 | $2.75 | $198K | -3.4% | -14.9% | -14.9% |
| TXMD | BUY | 2019-08-16 | 2019-08-19 | $2.93 | $29K | -1.4% | +37.5% | -6.1% |
| TXMD | BUY | 2019-08-12 | 2019-08-14 | $3.16 | $47K | +0.7% | +25.3% | +0.0% |
| TXMD | SELL | 2018-12-17 | 2018-12-19 | $3.68 | $1.4M | +1.6% | +33.8% | +45.0% |
| TXMD | SELL | 2018-12-04 | 2018-12-06 | $4.78 | $1.2M | -21.7% | +1.7% | +21.3% |
| TXMD | SELL | 2018-11-28 | 2018-11-30 | $4.98 | $1.9M | -19.9% | -24.9% | +12.8% |
| TXMD | SELL | 2018-11-14 | 2018-11-16 | $4.91 | $1.3M | +3.3% | -25.6% | +18.4% |
| TXMD | SELL | 2018-10-23 | 2018-10-25 | $5.35 | $1.3M | -12.8% | -9.7% | -5.2% |
| TXMD | SELL | 2018-10-09 | 2018-10-11 | $5.86 | $1.5M | -5.6% | -17.4% | -21.8% |
| TXMD | SELL | 2018-09-25 | 2018-09-27 | $6.78 | $1.7M | -11.0% | -29.4% | -43.2% |
| TXMD | SELL | 2018-09-10 | 2018-09-12 | $6.10 | $1.5M | +5.5% | -14.6% | -33.4% |
| TXMD | SELL | 2014-03-26 | 2014-03-28 | $6.70 | $2.4M | -26.4% | -1.1% | -1.1% |
| TXMD | SELL · 10b5-1 | 2014-02-24 | 2014-02-26 | $6.31 | $158K | -26.4% | -1.1% | -1.1% |
| TXMD | SELL · 10b5-1 | 2014-01-28 | 2014-01-30 | $6.15 | $154K | -26.4% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.